These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7195231)

  • 1. A double blind crossover tolerance study of AR-L 115 BS in health volunteers.
    Van Wayjen RG; vd Ende A; Schuijt C
    Arzneimittelforschung; 1981; 31(1a):242-3. PubMed ID: 7195231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Onset and magnitude of cardiovascular response to dobutamine and AR-L 115 BS, a new positive inotropic agent with additional vasodilating activity, in normal subjects.
    Benedikter L; Mey T
    Arzneimittelforschung; 1981; 31(1a):239-42. PubMed ID: 7195230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hemodynamic effect of AR-L 115 BS, a new positive-inotropic agent, in patients with left ventricular failure.
    Wollschläger H; Drexler H; Löllgen H; Just H
    Arzneimittelforschung; 1981; 31(1a):248-50. PubMed ID: 7195233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence on hemodynamic parameters after parenteral administration of AR-L 115 BS in patients with acute myocardial infarction.
    Nebel W; Sabin G; Surawitzki G
    Arzneimittelforschung; 1981; 31(1a):251-3. PubMed ID: 7195234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative cardiovascular effects of three benzimidazole derivatives, AR-L 57 BS, AR-L 100 BS, and AR-L 115 BS.
    Diederen W; Kadatz R
    Arzneimittelforschung; 1981; 31(1a):141-6. PubMed ID: 7195207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of AR-L 115 BS, a new cardiotonic compound, on cardiac contractility, heart rate and blood pressure in anaesthetized and conscious animals.
    Diederen W; Kadatz R
    Arzneimittelforschung; 1981; 31(1a):146-50. PubMed ID: 7195208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic effects of single-dose administration of AR-L 115 BS in patients with coronary artery disease.
    Weikl A; Kohlschütter S; Durst OE; Lang E
    Arzneimittelforschung; 1981; 31(1a):244-7. PubMed ID: 7195232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of AR-L 115 BS on contractility dynamics of the isolated, metabolically supported dog heart (author's transl)].
    Hockerts T; Höcht B; Broll R; Trenkel K; Sieber J; Kilian A; Brendle B
    Arzneimittelforschung; 1981; 31(1a):157-61. PubMed ID: 7195211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new orally active positive inotropic substance: AR-L 115 BS.
    Ruffmann KD; Mehmel HC; Kübler W
    Arzneimittelforschung; 1981; 31(1a):271-3. PubMed ID: 7195240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acute effect of a new positive inotropic agent (AR-L 115 BS) on cardiac hemodynamics and contractility in patients with severe chronic congestive heart failure.
    Hauf GF; Bubenheimer P; Roskamm H
    Arzneimittelforschung; 1981; 31(1a):253-6. PubMed ID: 7195235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic activity of different doses of sulmazole by infusion.
    Mendiola-García A; Fernández-Fernández JL; Tello-Arias A; Camacho-Rivera B
    Arzneimittelforschung; 1983; 33(11):1594-8. PubMed ID: 6686455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new non-glycoside, non-adrenergic cardiotonic agent AR-L 115 BS. Hemodynamic proof of its efficacy after both i.v. and oral administration.
    Thormann J; Kramer W; Schlepper M
    Arzneimittelforschung; 1981; 31(1a):273-8. PubMed ID: 7195241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of AR-L 115 BS with isoprenaline on hemodynamic parameters in the isolated guinea pig heart.
    Schrader J
    Arzneimittelforschung; 1981; 31(1a):183-5. PubMed ID: 7195216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of AR-L 115 BS on hemodynamics, myocardial oxygen consumption and cardiac pumping efficiency.
    Hellige G; Baller D; Ensink FB; Zipfel J; Wolpers HG; Bretschneider HJ
    Arzneimittelforschung; 1981; 31(1a):155-6. PubMed ID: 7195210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the acute effect of AR-L 115 BS, a new positive-inotropic agent in patients with exercise-induced heart failure.
    Drexler H; Wollschläger H; Löllgen H; Just H
    Arzneimittelforschung; 1981; 31(1a):259-62. PubMed ID: 7195237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic and humoral effects at rest and after head-up tilt tests during 24-hour infusion of a new nitrate ester, ITF 296, compared with ISDN and placebo in healthy volunteers: a double-blind, randomized, within-subject study.
    Sardina M; Warrington SJ; Boyce M; Johnston A; Bianchini C
    J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S80-90. PubMed ID: 8839231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of AR-L 115 BS on hemodynamics and contractility of the heart in cardiac patients.
    Stauch M; Nechwatal W
    Arzneimittelforschung; 1981; 31(1a):267-71. PubMed ID: 7195239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radio synthesis of 14C-2-[(2-Methoxy-4-methyl-sulfinyl)phenyl]-1H-imidazo[4,5-b]pyridine (AR-L 115 BS) (author's transl)].
    Zipp H; Roth W; Zimmer A; Mitarbeit U; Switek H
    Arzneimittelforschung; 1981; 31(1a):200-3. PubMed ID: 7195221
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular effects of the positive inotropic agents pimobendan and sulmazole in vivo.
    von Meel JC
    Arzneimittelforschung; 1985; 35(1A):284-8. PubMed ID: 4039168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
    Kisicki JC; Fiske K; Lyne A
    Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.